Meeting
2018 Genitourinary Cancers Symposium
Clinical outcomes of patients with histologic variants of urothelial carcinoma treated with tetra-modality bladder-sparing protocol incorporating consolidative partial cystectomy.
Authors
Toshiki Kijima
Tokyo Medical and Dental University Graduate School, Tokyo, Japan
Toshiki Kijima , Soichiro Yoshida , Minato Yokoyama , Junichiro Ishioka , Yoh Matsuoka , Kazutaka Saito , Kazunori Kihara , Yasuhisa Fujii
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer, Urothelial Carcinoma, and Penile, Urethral, and Testicular Cancers
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers
Sub Track
Urothelial Carcinoma
Citation
J Clin Oncol 36, 2018 (suppl 6S; abstr 490)
DOI
10.1200/JCO.2018.36.6_suppl.490
Abstract #
490
Poster Bd #
J19
Abstract Disclosures
Similar Posters
Poster
2019 Genitourinary Cancers Symposium
Clinical outcomes of muscle-invasive bladder cancer patients with hydronephrosis treated with tetra-modality bladder sparing therapy incorporating consolidative partial cystectomy.
First Author: Toshiki Kijima
Poster
2019 Genitourinary Cancers Symposium
The impact of histologic variants of urothelial carcinoma on clinical outcomes following trimodal bladder-preserving therapy.
First Author: Yoshiyuki Nagumo
Poster
2020 Genitourinary Cancers Symposium
The efficacy of trimodal chemoradiotherapy with gemcitabine and cisplatin as a bladder-preserving strategy for the treatment of muscle invasive bladder cancer: A single-arm prospective study.
First Author: Hiroaki Matsumoto
Poster
2019 Genitourinary Cancers Symposium
Comparing clinical outcomes between patients with urothelial carcinoma who treated neoadjuvant chemotherapy by gemcitabine-cisplatin and dose-dense MVAC.
First Author: Yongjune Lee